At the American Society for Radiation Oncology Annual Meeting (ASTRO 2023), Philips will unveil their groundbreaking MR and CT developments that are set to transform radiation therapy. By harnessing the power of MR-guided radiotherapy and the unique capabilities of their Spectral CT 7500 scanner, Philips is revolutionizing the way radiation oncologists target and treat cancer. Join us as we explore how these cutting-edge technologies are enhancing accuracy, improving patient outcomes, and driving innovation in cancer care.
Enhancing Precision with MR-Guided Radiotherapy
Discover how MR-guided radiotherapy is revolutionizing the precision and accuracy of radiation therapy.
MR-guided radiotherapy is a game-changer in the field of radiation therapy. By combining the imaging capabilities of MRI with the targeted delivery of radiation, this innovative approach allows radiation oncologists to visualize tumors in real-time and adjust treatment plans accordingly.
With MR-guided radiotherapy, oncologists can track tumor motion, account for changes in tumor size and shape, and adapt the radiation beam to precisely target the tumor while sparing surrounding healthy tissues. This level of precision minimizes the risk of damage to critical structures and maximizes the effectiveness of the treatment.
By leveraging MR-guided radiotherapy, radiation oncologists can deliver higher doses of radiation to the tumor, leading to improved tumor control rates and better patient outcomes. This groundbreaking technology is transforming the way we treat cancer, offering new hope to patients around the world.
Unleashing the Potential of Spectral CT in Radiation Therapy
Explore how Spectral CT is revolutionizing radiation therapy planning and treatment.
Spectral CT is taking radiation therapy planning to the next level by providing detailed information about tumor morphology and physiology. By capturing data at multiple energy levels, Spectral CT enhances the visibility of tumor boundaries and internal structures, improving the accuracy of dose calculation and tumor targeting.
With Spectral CT, oncologists can assess tissue perfusion and determine which parts of the tumor are most active. This valuable information helps in contouring and dose profiling, ensuring that the radiation therapy is tailored to the unique characteristics of the tumor.
Furthermore, Spectral CT is particularly beneficial for visualizing tumors that are subject to movement, such as those in the lungs. It allows radiation oncologists to account for tumor motion and deliver precise radiation doses, leading to more effective treatment outcomes.
Optimizing Radiation Therapy Planning with MR-Based Solutions
Learn how MR-based solutions are revolutionizing radiation therapy planning and simulation.
MR-based solutions are transforming radiation therapy planning and simulation by providing highly detailed images that accurately depict tumor boundaries. By utilizing advanced MR technologies, oncologists can precisely define the treatment area and create personalized treatment plans for each patient.
One notable advancement is the ability to scan brain and Head and Neck patients in the diagnostic coil, improving patient comfort and image quality. Additionally, In-Bore connect capabilities allow patients to watch videos during their scans, enhancing their overall experience.
At ASTRO 2023, Dr. Cornelis Raaijmakers of University Medical Center Utrecht will share the latest results from using MR-based radiotherapy planning and simulation systems for brain and head and neck cancer patients. These advancements in MR technology are revolutionizing radiation therapy, leading to better outcomes for cancer patients worldwide.
Conclusion
The advancements showcased by Philips at ASTRO 2023 are revolutionizing radiation therapy and transforming the way we treat cancer. MR-guided radiotherapy, Spectral CT, and MR-based solutions are enhancing precision, improving accuracy, and optimizing treatment planning. These technologies are empowering radiation oncologists to deliver personalized, targeted therapies with minimal impact on healthy tissues, leading to better patient outcomes.
FQA :
How is MR-guided radiotherapy improving the accuracy of radiation therapy?
MR-guided radiotherapy combines the imaging capabilities of MRI with targeted radiation delivery, allowing oncologists to visualize tumors in real-time and adjust treatment plans accordingly. This precision improves accuracy by accounting for changes in tumor size, shape, and motion, while sparing surrounding healthy tissues.
What benefits does Spectral CT offer in radiation therapy?
Spectral CT provides detailed information about tumor morphology and physiology, enhancing the accuracy of dose calculation and tumor targeting. It allows oncologists to assess tissue perfusion and determine the most active parts of the tumor, contributing to precise contouring and dose profiling. Spectral CT is particularly valuable for visualizing tumors subject to movement, such as those in the lungs.
How are MR-based solutions optimizing radiation therapy planning?
MR-based solutions provide highly detailed images that accurately depict tumor boundaries, enabling oncologists to create personalized treatment plans. Advanced MR technologies, such as scanning brain and Head and Neck patients in the diagnostic coil, improve patient comfort and image quality. In-Bore connect capabilities enhance the patient experience by allowing them to watch videos during scans.
